However, due to the lack of intrinsic TfR1 selectivity may make it not suitable for glioma targeting therapy, but adopted with other tumor-targeting capabilities, such as integrin targeting moieties might be utilized for tumors across a broad spectrum. Here, TFRC is linked to central nervous system cancer.